Ligand validation:4L35

22B: BACTERIORUBERIN

22B is a Ligand Of Interest in 4L35 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4L35_22B_A_302	0%	11%	0.48	0.534	2.36	2.01	12	13	0	0	69%	0.6852
4JR8_22B_A_302	24%	13%	0.195	0.88	2.2	1.92	11	12	0	0	69%	0.6852
3A7K_22B_B_300	20%	6%	0.215	0.819	3.22	1.98	20	19	2	0	100%	1
2Z55_22B_A_270	19%	18%	0.273	0.866	2.26	1.48	10	14	3	0	100%	1
3QBI_22B_B_300	15%	4%	0.197	0.846	3.54	2.43	10	11	3	0	50%	0.5
2EI4_22B_A_270	14%	17%	0.268	0.819	2.37	1.45	9	15	1	0	100%	1
3QBK_22B_B_300	9%	4%	0.215	0.792	3.65	2.45	11	10	1	0	50%	0.5

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.